The MAPK Pathway as a Therapeutic Target in Cancer Research

Article   Nov 30, 2017 | by Jack Rudd, Senior Editor for Technology Networks

 
The MAPK Pathway as a Therapeutic Target in Cancer Research

Jack Rudd

Managing Editor

 
 
 

RELATED ARTICLES

How the Internet of Things is Connecting Up Lab Ecosystems

Article

If the 20th century was about improving technology, the 21st century has focused on improving access to technology. In this article, we look at how the "Internet of Things" (IoT) movement is changing research, and find that IoT in the lab is at an important crossroads

READ MORE

Proteogenomics: The Path to Personalized Medicine?

Article

Proteogenomics - a multiomic discipline which combines gene, protein and RNA data, has potential to give a true systems perspective on the human body. We look at the techniques that enable proteogenomics analysis, and the potential of the field in the clinic to personalize medicine and battle cancer.

READ MORE

Multiomics and Metaproteomics: Why More Is Better In Proteomic Data Analysis

Article

Developments in next-gen multi-omics have made it possible to generate and process massive amounts of data that cover anything from genomic mutations to metabolomic and microbiological processes. However, handling and analyzing all this data continues to present challenges to even the most experienced bioinformatics experts. In this article we explore some of the solutions and advancements in multi-omics and metaproteomics data analysis approaches.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy